View in EDS HTML Full Text PDF Full Text

Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center.

Saved in:
Bibliographic Details
Title: Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center.
Authors: Schwörer I; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Huwer S; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Rautenberg B; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Neubauer J; Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Juhasz-Böss I; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Jung L; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Source: Frontiers in oncology [Front Oncol] 2026 Feb 19; Vol. 16, pp. 1732304. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41800034
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schwörer+I%22">Schwörer I</searchLink>; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Huwer+S%22">Huwer S</searchLink>; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Rautenberg+B%22">Rautenberg B</searchLink>; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Neubauer+J%22">Neubauer J</searchLink>; Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Juhasz-Böss+I%22">Juhasz-Böss I</searchLink>; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Jung+L%22">Jung L</searchLink>; Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Feb 19; Vol. 16, pp. 1732304. <i>Date of Electronic Publication: </i>2026 Feb 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41800034
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1732304
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1732304
    Titles:
      – TitleFull: Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schwörer I
      – PersonEntity:
          Name:
            NameFull: Huwer S
      – PersonEntity:
          Name:
            NameFull: Rautenberg B
      – PersonEntity:
          Name:
            NameFull: Neubauer J
      – PersonEntity:
          Name:
            NameFull: Juhasz-Böss I
      – PersonEntity:
          Name:
            NameFull: Jung L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 02
              Text: 2026 Feb 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1